Thyroid hormones target nearly every tissue in the body, but their effects are not equal everywhere. The two main hormones, T4 (thyroxine) and T3 (triiodothyronine), act on the heart, brain, liver, bones, fat tissue, and muscles through receptors found both inside the cell nucleus and on the cell surface. T3 is the more active form, binding to nuclear receptors with two to three times the affinity of T4. Understanding these targets helps explain why thyroid dysfunction causes such wide-ranging symptoms.
How Thyroid Hormones Reach Their Targets
The thyroid gland primarily releases T4, which circulates through the bloodstream and gets converted into T3 inside target tissues by enzymes that strip away one iodine atom. T3 then enters the cell nucleus, where it pairs with a partner protein and latches onto specific stretches of DNA called thyroid hormone response elements. Without T3 present, these receptor complexes actually sit on DNA and suppress gene activity. When T3 binds, the receptor changes shape, releases the suppressing proteins, and recruits activating proteins that kick-start gene transcription. This on/off switch mechanism is how thyroid hormones control hundreds of genes across different organs.
Two main receptor types carry out this work. The alpha receptor (found predominantly in the heart, bone, and brain) and the beta receptor (concentrated in the liver and responsible for regulating thyroid-stimulating hormone production in the pituitary gland). These receptors are not fully interchangeable. Research in knockout animal models shows that the alpha receptor is essential for normal bone and intestinal development, while the beta receptor is the primary regulator of the hormonal feedback loop that controls how much thyroid hormone the body makes. Redundancy between the two is limited and applies to only a small number of functions.
The Heart
Heart muscle is one of the most sensitive targets of thyroid hormone. T3 directly switches on genes for two critical cardiac proteins: alpha-myosin heavy chain, which determines how fast heart muscle contracts, and SERCA, a calcium pump in heart muscle cells that controls how quickly the heart relaxes between beats. At the same time, T3 suppresses beta-myosin heavy chain, a slower contracting protein, reducing it to as little as 5% of normal levels in cell studies. The net effect is a heart that beats faster, contracts more forcefully, and relaxes more efficiently.
This is why hyperthyroidism commonly causes a rapid or pounding heartbeat, while hypothyroidism leads to a slower heart rate and sometimes heart failure. The two receptor types divide the labor in cardiac cells: the alpha receptor drives the increase in contraction speed and cell size, while the beta receptor handles the suppression of the slower contractile protein and activation of the calcium pump.
The Brain and Nervous System
During fetal and early postnatal development, thyroid hormones are essential for building a functional brain. T3 regulates genes involved in neuron migration, the formation of myelin (the insulating sheath around nerve fibers), and the maturation of key cell types in the cerebral cortex. Specific gene targets include myelin basic protein, neurogranin (important for synaptic signaling), neuronal cell adhesion molecules, and reelin, a protein that guides neurons to their correct positions during cortical development.
In the developing human cortex, specialized cells called outer radial glia express the enzymes needed to convert T4 into T3 locally. The T3 they produce appears to drive neurogenesis and guide the migration and differentiation of newly formed neurons and interneurons, which already carry thyroid hormone receptors. Hypothyroidism during this critical window reduces the number of Cajal-Retzius cells (early cortical organizers) and slashes reelin levels, disrupting the architecture of the developing brain. This is why congenital hypothyroidism, if untreated, causes intellectual disability.
Metabolism and Heat Production
A major reason thyroid hormones affect body weight, energy, and temperature is their action on cellular energy machinery. One key target is a sodium-potassium pump embedded in the membrane of most cells. This pump, which can consume 25 to 30% of a cell’s total energy budget in active tissues, is directly upregulated by T3. Thyroid hormones increase both the production and the membrane insertion of pump proteins, forcing cells to burn more fuel just to maintain basic ion balance. This is a large part of what determines your basal metabolic rate.
For body heat specifically, thyroid hormones target brown fat tissue. Brown fat generates warmth through a protein called uncoupling protein 1 (UCP1), which sits in the inner membrane of mitochondria and essentially short-circuits the normal energy-production process so that fuel is burned as heat instead of being stored as chemical energy. T3 is required for UCP1 production, and this requirement cannot be bypassed by other signals. Studies in hypothyroid animals show markedly reduced UCP1 levels, while T3 treatment can induce UCP1 even under conditions of minimal nervous system stimulation of brown fat. This explains the cold intolerance that people with hypothyroidism commonly experience.
The Liver and Cholesterol
The liver is a primary target of thyroid hormones, largely through the beta receptor. One of the most clinically relevant effects is the regulation of LDL receptors on liver cells. These receptors pull LDL cholesterol (“bad” cholesterol) out of the bloodstream for breakdown. T3 increases LDL receptor production through two routes: it directly activates LDL receptor gene transcription, and it indirectly boosts transcription through a cholesterol-sensing pathway involving a protein called SREBP-2.
In hypothyroidism, the number of these liver receptors drops, which is why elevated LDL cholesterol is one of the hallmark lab findings. Thyroid hormone replacement therapy restores LDL receptor activity and normalizes cholesterol levels. This connection between thyroid function and cardiovascular risk is one reason doctors routinely check thyroid levels when cholesterol is unexpectedly high.
Bone and Growth Plates
In growing bones, thyroid hormones target chondrocytes, the cartilage cells within growth plates. T3 signals these cells to progress through their life cycle: from resting, to proliferating, to swelling into hypertrophic cells, and finally to undergoing programmed cell death so that cartilage can be replaced by bone. This process, called endochondral ossification, is how bones lengthen during childhood and adolescence.
The alpha receptor dominates in bone tissue. Animal studies show that disrupting the alpha receptor alone causes significant delays in skeletal maturation, and adding a beta receptor disruption on top does not make things worse. This means the alpha receptor is doing nearly all the work in bone. Children with untreated hypothyroidism have delayed bone age and short stature precisely because this growth plate signaling is impaired.
Targets on the Cell Surface
Beyond the well-established nuclear receptor pathway, thyroid hormones also act on a receptor sitting on the outer surface of cells. This receptor is part of a protein called integrin alpha-v beta-3, and it responds primarily to T4 rather than T3, which is the opposite of nuclear signaling. When T4 binds this surface receptor, it triggers a rapid signaling cascade that promotes cell proliferation without requiring changes in gene transcription. This non-genomic pathway is notably active in cancer cells and blood vessel cells, where it can stimulate growth. Compounds that block T4 from binding this integrin receptor are being studied as a strategy to inhibit these proliferative effects.
The existence of this surface receptor helps explain why thyroid hormones can produce some effects within minutes, far too fast for the hours-long process of gene transcription. In lung tissue, for example, T3 rapidly increases sodium-potassium pump activity at the cell membrane by triggering the movement of pre-made pump proteins from internal storage pools to the surface, a process that happens independently of new gene expression.